Fingerprint
Dive into the research topics of 'Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models
Emmy D.G. Fleuren, Yvonne M.H. Versleijen-Jonkers, Melissa H.S. Roeffen, Gerben M. Franssen, Uta E. Flucke, Peter J. Houghton, Wim J.G. Oyen, Otto C. Boerman, Winette T.A. Van Der Graaf
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations